1. The S&P 500 bull market has seen strong gains over the past three years, fueled by technology stocks and optimism about lower interest rates. History suggests that bull markets typically last longer than bear markets, pointing to potential future gains for investors.
2. Nvidia, a leading AI chip designer, has seen soaring earnings and is well-positioned to benefit from the growing AI infrastructure spending. With AI models relying on chips for their operations, Nvidia is set for continued success in the years ahead.
3. Eli Lilly’s weight loss drug portfolio has driven blockbuster revenue, with promising results from its latest oral weight loss candidate. As the company expands its weight loss offerings, now may be an opportune time to invest in this pharma player for both safety and growth.
4. American Express continues to see steady earnings growth, with a growing base of younger customers contributing to its success. With a focus on high-income customers and a strong presence in the payment card market, American Express is positioned for further growth in the future.
5. CoreWeave, an AI-focused company, has seen significant revenue growth and offers high-powered chips for AI workloads. With the potential for continued growth in 2026 and beyond, CoreWeave presents a compelling opportunity for investors looking to capitalize on the AI boom.
6. Viking Therapeutics aims to enter the billion-dollar weight loss drug market with promising phase 3 and phase 2 candidates. As demand in this market remains high, Viking could emerge as a strong contender alongside established players like Eli Lilly and Novo Nordisk.
7. Meta Platforms, trading at a reasonable valuation, offers investors a top AI bet with a focus on revenue supercharged by AI investments. With a strong track record of growth and profitability, Meta is well-positioned for future success in the tech sector.
8. Abbott Laboratories, a Dividend King with a diverse portfolio of healthcare products, has seen consistent dividend growth over the years. With industry-leading products and a strong free cash flow, Abbott is a solid healthcare stock to consider for long-term investment.
9. UnitedHealth Group, the largest U.S. health insurer, is addressing challenges in the healthcare industry by implementing cost-cutting measures and leveraging AI for efficiency gains. With a cheap valuation and promising recovery prospects, UnitedHealth presents a compelling opportunity for investors in 2026.
10. Chewy, an e-commerce player specializing in pet products, has a loyal customer base and steady growth, driven by its AutoShip sales program. Profitable and debt-free, Chewy offers investors visibility on future sales and a strong position in the consumer goods market.
11. Amazon, a market giant with a track record of growth and profitability, is poised to capitalize on the potential of AI in e-commerce and cloud computing. With AI already driving revenue growth for Amazon Web Services, the company’s future success looks promising for investors in 2026 and beyond.

Read more at Nasdaq: My Top 10 Stocks to Buy for 2026